Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Frilling

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Frontiers in Medicine|January 11, 2021
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational StudyStefano Partelli, John K Ramage, Sara Massironi, et al.
The British Journal of Surgery|August 20, 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trialStefano Partelli, Sara Massironi, Alessandro Zerbi, et al.
Nature Genetics|June 20, 2018
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumorsMariano J Alvarez, Prem S Subramaniam, Laura H Tang, et al.
The Lancet. Oncology|January 14, 2023
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort studyCédric Nesti, Konstantin Bräutigam, Marta Benavent, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Frontiers in Medicine|January 11, 2021
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational StudyStefano Partelli, John K Ramage, Sara Massironi, et al.
The British Journal of Surgery|August 20, 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trialStefano Partelli, Sara Massironi, Alessandro Zerbi, et al.
Nature Genetics|June 20, 2018
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumorsMariano J Alvarez, Prem S Subramaniam, Laura H Tang, et al.
The Lancet. Oncology|January 14, 2023
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort studyCédric Nesti, Konstantin Bräutigam, Marta Benavent, et al.
Pageof 15